Search Results

Booz Allen Hamilton announced it was awarded a seven-year, $419 million contract with the National Science Foundation for Information Technology Mission Application Support.

As March approaches, the National Kidney Foundation is gearing up to observe National Kidney Month, a crucial time dedicated to raising awareness about kidney health and chronic kidney disease.

The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.

The Foundation for the National Institutes of Health announces that Love Collins, III, has joined as Vice President of Advancement.

The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis.

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announces that it will be a Bronze Sponsor for the Foundation for Ichthyosis & Related Skin Types (FIRST) 2024 national conference in Albuquerque, New Mexico from June 28-30, 2024.

The Foundation for the National Institutes of Health announces two additions to the FNIH Board of Directors: James W. Down, former Vice Chairman of Mercer Management Consulting, and Perry Steiner, Chairman and CEO of Xactus.

Aurinia Pharmaceuticals Inc., announced the presentation of results from an updated cost-effective analysis of LUPKYNIS, a second generation calcineurin inhibitor, at the annual National Kidney Foundation Spring Clinical Meeting 2024 taking place in Long Beach, CA, May 14-18.